Diseases, Conditions, Syndromes

Vaccine against Chikungunya successful in phase 1

The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information ...

Diseases, Conditions, Syndromes

A US clinical trial for COVID-19 mRNA vaccine

The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the virus that causes COVID-19 disease.

Medications

CDC preparing vaccine for new swine flu

(HealthDay) -- Only 29 human cases of a new strain of "swine" flu have been identified in two years, but the U.S. Centers for Disease Control and Prevention is making sure it's prepared should the H3N2 strain become more ...

Diseases, Conditions, Syndromes

WHO tempers quick vaccine hopes

The World Health Organization says it does not expect widespread immunisation against Covid-19 until mid-2021, despite growing expectations in the United States, the worst-hit nation, that a vaccine could be released within ...

Diseases, Conditions, Syndromes

Scientists develop improved, potentially safer Zika vaccine

The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas. It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and ...

Diseases, Conditions, Syndromes

New molecule shows promise in HIV vaccine design

Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around ...

page 8 from 40